Endomag was founded in 2007 out of research conducted at the University College London (UCL) and the University of Houston.
Endomag has grown from an academic research project into a global company with the belief that its technology can become the new standard of care across the world.
Endomag products are now routinely used by over 1,350+ hospitals in more than 45 countries. Over 500,000 women will have now accessed more precise and less invasive breast cancer treatment.
